Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pilot study of recombinant TSH replacement therapy in central hypothyroidism
2007-005242-21Phase 2Completed
- Sponsor
- The Christie
- Start
- Feb 2008
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 2, single-arm trial of thyrotropin alfa in central hypothyroidism (CeH), sponsored by The Christie. Primary endpoint: Thyroid function parameters. Started Feb 2008; status: completed.
02
Drugs
thyrotropin alfa
03
Conditions
central hypothyroidism (CeH)
Beyond the preview
Go deeper on 2007-005242-21.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2007-005242-21.